With FDA's blessing, PhysioSonics looks to market brain monitor

PhysioSonics, a University of Washington spinout, snagged FDA clearance for its Presto 1000 Flow Monitor, and now the company is on the hunt for a commercial partner, Xconomy reports. The device allows physicians to automate brain blood flow monitoring of stroke patients, providing a continuous readout instead of the period snapshots generated by ultrasound transducers. PhysioSonics has raised a total of $22 million from investors and government sources, according to Xconomy, and it aims to get the device on the market next year. Report

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.